CASA - TRVN ZLAB and BRFS are among pre market gainers
2023-05-31 08:20:18 ET
- WANG & LEE GROUP ( WLGS ) +45% .
- Marker Therapeutics ( MRKR ) +37% Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells.
- LL Flooring Holdings ( LL ) +20% jumps after founder offers $5.76 a share for company (update).
- Trevena ( TRVN ) +16% .
- Mobilicom ( MOB ) +10% .
- Aquestive Therapeutics ( AQST ) +9% Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study
- Casa Systems ( CASA ) +9% .
- BRF ( BRFS ) +7% .
- Precigen ( PGEN ) +7% Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with Recurrent or Metastatic Cervical Cancer.
- Netcapital ( NCPL ) +7% .
- Zai Lab ( ZLAB ) +7% .
- IceCure Medical ( ICCM ) +6% India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country
- Sharecare ( SHCR ) +6% concludes strategic review, announces share repurchase program.
For further details see:
TRVN, ZLAB and BRFS are among pre market gainers